A clinical trial to study the effect of dhanyamla dhara in management of whole body pain

Randomized controlled clinical trial of dhanyamla dhara according to bhaishajyaratnavali in sarvangavata - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059502

Enrollment

Registered

2023-11-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G892- Chronic pain, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 The patient having sign and symptoms of sarvangavata like gatraspuran bhanjan vedana sandhi sputan toda bheda sphuran sthambhan akshepan swap sandhi akunchan kampan 2 Patient irrespective with gender 3 Patient indicated for swedan karma 4 controlled HTN

Exclusion criteria

Exclusion criteria: 1 Patient contraindicated for swedan karma 2 Pregnant lactating mother and rajswala 3 Patient with severe complications of vata roga

Design outcomes

Primary

Measure	Time frame
To evaluate efficacy of dhanyamla dhara in management of sarvanga vata Timepoint: 4 weeks	—

Secondary

Measure	Time frame
To review sarvangavata in detail parishek karma Timepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Alaknanda Kulkarni

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

vdalakanandakulkarni@gmail.com9689049577

Outcome results